Answers are grounded in this paper and cite their sources.
Background: to chloroquine (CQ), pyrimethamine and artemisinin-based combination therapies (ACTs) in three sites in southern Côte d'Ivoire. Methodology: resistance to CQ, pyrimethamine and ACTs, respectively was determined. Data were analysed using R statistical software, version 3.2.2. Results: gene also showed a predominance of the YRICMR allelic form representing the sensitive haplotype (72/93, i.e. 78.49%). Conclusions: gene conferring resistance to artemisinin derivatives were observed at any of the study sites. The study thus showed that the ACTs used for first-line treatment of malaria in Côte d'Ivoire are still effective.
No takes yet. Share an insight, caveat, or question.
Dagnogo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: